Abstract

Oncogene-induced DNA replication stress (RS) and consequent pathogenic R-loop formation are known to impede S phase progression. Nonetheless, cancer cells continuously proliferate under such high-stressed conditions through incompletely understood mechanisms. Here, we report taurine upregulated gene 1 (TUG1) long noncoding RNA (lncRNA), which is highly expressed in many types of cancers, as an important regulator of intrinsic R-loop in cancer cells. Under RS conditions, TUG1 is rapidly upregulated via activation of the ATR-CHK1 signaling pathway, interacts with RPA and DHX9, and engages in resolving R-loops at certain loci, particularly at the CA repeat microsatellite loci. Depletion of TUG1 leads to overabundant R-loops and enhanced RS, leading to substantial inhibition of tumor growth. Our data reveal a role of TUG1 as molecule important for resolving R-loop accumulation in cancer cells and suggest targeting TUG1 as a potent therapeutic approach for cancer treatment.

Proliferation of cancer cells leads to replication stress through incompletely understood mechanisms. Here, the authors show that the long noncoding RNA TUG1 resolves R-loops and reduces replication stress in cancer cells.

Details

Title
TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation
Author
Suzuki, Miho M. 1   VIAFID ORCID Logo  ; Iijima, Kenta 2   VIAFID ORCID Logo  ; Ogami, Koichi 3   VIAFID ORCID Logo  ; Shinjo, Keiko 1   VIAFID ORCID Logo  ; Murofushi, Yoshiteru 1   VIAFID ORCID Logo  ; Xie, Jingqi 1   VIAFID ORCID Logo  ; Wang, Xuebing 1 ; Kitano, Yotaro 4   VIAFID ORCID Logo  ; Mamiya, Akira 1   VIAFID ORCID Logo  ; Kibe, Yuji 5 ; Nishimura, Tatsunori 1 ; Ohka, Fumiharu 4   VIAFID ORCID Logo  ; Saito, Ryuta 4   VIAFID ORCID Logo  ; Sato, Shinya 6   VIAFID ORCID Logo  ; Kobayashi, Junya 7   VIAFID ORCID Logo  ; Yao, Ryoji 8   VIAFID ORCID Logo  ; Miyata, Kanjiro 9 ; Kataoka, Kazunori 10   VIAFID ORCID Logo  ; Suzuki, Hiroshi I. 11   VIAFID ORCID Logo  ; Kondo, Yutaka 12   VIAFID ORCID Logo 

 Nagoya University Graduate School of Medicine, Division of Cancer Biology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
 Nagoya University Graduate School of Medicine, Division of Cancer Biology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Hamamatsu University School of Medicine, Laboratory Animal Facilities and Services, Preeminent Medical Photonics Education and Research Center, Hamamatsu, Japan (GRID:grid.505613.4) (ISNI:0000 0000 8937 6696) 
 Nagoya University Graduate School of Medicine, Division of Molecular Oncology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
 Nagoya University Graduate School of Medicine, Department of Neurosurgery, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
 Nagoya University Graduate School of Medicine, Division of Cancer Biology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Nagoya University Graduate School of Medicine, Department of Neurosurgery, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
 Kanagawa Cancer Center Research Institute, Molecular Pathology and Genetics Division, Yokohama, Japan (GRID:grid.414944.8) (ISNI:0000 0004 0629 2905) 
 International University of Health and Welfare, School of Health Sciences at Narita, Narita, Japan (GRID:grid.411731.1) (ISNI:0000 0004 0531 3030) 
 Japanese Foundation for Cancer Research, Department of Cell Biology, Koto-ku, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131) 
 The University of Tokyo, Department of Materials Engineering, Graduate School of Engineering, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
10  Kawasaki Institute of Industrial Promotion, Innovation Center of NanoMedicine, Kawasaki-ku, Japan (GRID:grid.493442.c) (ISNI:0000 0004 5936 3316); The University of Tokyo, Institute for Future Initiatives, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
11  Nagoya University Graduate School of Medicine, Division of Molecular Oncology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Tokai National Higher Education and Research System, Institute for Glyco-core Research (iGCORE), Nagoya, Japan (GRID:grid.27476.30) 
12  Nagoya University Graduate School of Medicine, Division of Cancer Biology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Tokai National Higher Education and Research System, Institute for Glyco-core Research (iGCORE), Nagoya, Japan (GRID:grid.27476.30) 
Pages
4521
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2854686014
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.